GSK
GSK signs $1.5 billion insomnia collaboration
July 16, 2008Sales and Marketing Actelion, GSK, insomnia
GlaxoSmithKline has joined forces with Swiss biopharmaceutical company Actelion to bring a new insomnia treatment to market.The deal could be …
Stout to quit as GSK restructures
December 10, 2007Sales and Marketing GSK, restructure
GlaxoSmithKline has unveiled new appointments to its board of directors and the departure of its current president of Pharmaceuticals David …
Avandia safety scare costs GSK $200m
July 26, 2007Sales and Marketing GSK
GlaxoSmithKline saw its performance in the second quarter of this year badly affected by a 22% slump in sales of …
GlaxoSmithKline plans five launches for 2007
February 9, 2007Sales and Marketing GSK
GlaxoSmithKline is planning to launch five new products in 2007, bringing to an end a long period for the company …
Packer Forbes scoops GSK Tycerb account
January 26, 2007Medical Communications GSK, Packer Forbest
London-based agency Packer Forbes Communications has won its first breast cancer account, to promote GlaxoSmithKline's potential blockbuster, Tycerb.The agency beat …
GSK gambles on success of new European pricing deal
September 25, 2006Sales and Marketing EU, GSK
GlaxoSmithKline has unveiled a new deal which could break the deadlock over the pricing of medicines in Europe.The groundbreaking agreement …
R&D Scoreboard poor gauge of pharma investment in the UK
November 8, 2005Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard
The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …
GSK makes strategic biotech acquisition
May 6, 2005Research and Development, Sales and Marketing GSK, biotech
GlaxoSmithKline will acquire a Seattle-based biotech that manufactures a key component in many of the candidates in its vaccine pipeline, …
Industry contributes to disaster relief in Asia
January 6, 2005Sales and Marketing AZ, GSK, WHO, disaster, relief, tsunami
Pharmaceutical companies have joined worldwide efforts to bring relief to areas devastated by the tsunami in Asia, donating money and …
GSK international pharma chief leaves for Chiron
October 29, 2003Sales and Marketing Chiron, David Stout, GSK, Howard Pien
GlaxoSmithKline’s head of international pharmaceutical operations, Howard Pien, is to leave the company to become Chief Executive of Chiron.Mr Pien’s …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
